References
- CDER-CBER. FDALabel CDER-CBER version [Internet]. [cited 2022 Jan 28]. Available from: http://fdalabel.fda.gov/fdalabel-r/ui/spl-summaries/criteria/98194.
- Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank. [cited 2022 Jan 28]. Montelukast. Available from: https://go.drugbank.com/drugs/DB00471.
- Center for Drug Evaluation and Research [CDER]. Drug safety information for healthcare professionals - updated information on leukotriene inhibitors: montelukast (marketed as singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR) [Internet]. Center for Drug Evaluation and Research; [cited 2022 Feb 14]. Available from: https://wayback.archive-it.org/7993/20170404172438/https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm165489.htm.
- Center for Drug Evaluation and Research [CDER]. FDA. FDA; 2020. [cited 2022 Jan 27]. FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug.
- Clarridge K, Chin S, Eworuke E, Seymour S. A boxed warning for montelukast: the FDA perspective. J Allergy Clin Immunol Pract. 2021;9(7):2638–2641. doi:10.1016/j.jaip.2021.02.057.
- Aschenbrenner DS. New boxed warning for singulair. Am J Nurs. 2020;120(7):27. doi:10.1097/01.NAJ.0000688208.18552.0c.
- Center for Drug Evaluation and Research [CDER]. Drug safety information for healthcare professionals - early communication about an ongoing safety review of montelukast (singulair) [Internet]. Center for Drug Evaluation and Research; [cited 2022 Jan 27]. Available from: https://wayback.archive-it.org/7993/20170406045734/https:/www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm070618.htm.
- Sansing-Foster V, Haug N, Mosholder A, Cocoros NM, Bradley M, Ma Y, Pennap D, Dee EC, Toh S, Pestine E, et al. Risk of psychiatric adverse events among montelukast users. J Allergy Clin Immunol Pract. 2021;9(1):385–393.e12. doi:10.1016/j.jaip.2020.07.052.
- Centers for Disease Control and Prevention [CDC]. International classification of diseases, (ICD-10-CM/PCS) transition- background [Internet]. 2023. [cited 2023 Oct 23]. Available from: https://www.cdc.gov/nchs/icd/icd10cm_pcs_background.htm.
- Swain RS, Taylor LG, Braver ER, Liu W, Pinheiro SP, Mosholder AD. A systematic review of validated suicide outcome classification in observational studies. Int J Epidemiol. 2019;48(5):1636–1649. doi:10.1093/ije/dyz038.
- Hedegaard H, Schoenbaum M, Claassen C, Crosby A, Holland K, Proescholdbell S. Issues in developing a surveillance case definition for nonfatal suicide attempt and intentional self-harm using international classification of diseases, tenth revision, clinical modification (ICD-10-CM) coded data. Natl Health Stat Report. 2018;(108):1–19.
- Simon GE, Shortreed SM, Boggs JM, Clarke GN, Rossom RC, Richards JE, Beck A, Ahmedani BK, Coleman KJ, Bhakta B, et al. Accuracy of ICD-10-CM encounter diagnoses from health records for identifying self-harm events. J Am Med Inform Assoc. 2022;29(12):2023–2031. doi:10.1093/jamia/ocac144.
- Sentinel Common Data Model | Sentinel Initiative [Internet]. [cited 2023 Oct 25]. Available from: https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model.
- Maro JC, Nguyen MD, Kolonoski J, Schoeplein R, Huang T-Y, Dutcher SK, Dal Pan GJ, Ball R. Six years of the US Food and Drug Administration’s postmarket active risk identification and analysis system in the sentinel initiative: implications for real world evidence generation. Clin Pharmacol Ther. 2023;114(4):815–824. doi:10.1002/cpt.2979.
- National Heart, Lung, and Blood Institute [NHLBI], National Institutes of Health [NIH]. 2020. Focused Updates to the Asthma Management Guidelines: a Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group [Internet]. 2020 [cited 2023 Nov 3]. Available from: https://www.nhlbi.nih.gov/resources/2020-focused-updates-asthma-management-guidelines.
- Sun JW, Rogers JR, Her Q, Welch EC, Panozzo CA, Toh S, Gagne JJ. Adaptation and validation of the combined comorbidity score for ICD-10-CM. Med Care. 2017;55(12):1046–1051. doi:10.1097/MLR.0000000000000824.
- Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64(7):749–759. doi:10.1016/j.jclinepi.2010.10.004.
- Shu D, Yoshida K, Fireman BH, Toh S. Inverse probability weighted Cox model in multi-site studies without sharing individual-level data. Stat Methods Med Res. 2020;29(6):1668–1681. doi:10.1177/0962280219869742.
- Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650–656. doi:10.1093/aje/kwp173.
- Department of Health and Human Services. 45 CFR 46.102 – code of federal regulations [Internet]. [cited 2023 Jul 27]. Available from: https://www.ecfr.gov/current/title-45/part-46/section-46.102.
- Office of the Federal Register Federal policy for the protection of human subjects. Part IX: rules and regulations. Fed Regist. 2017;82(12):6167–7630.
- Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–3107. doi:10.1002/sim.3697.
- Paljarvi T, Forton J, Luciano S, Herttua K, Fazel S. Analysis of neuropsychiatric diagnoses after montelukast initiation. JAMA Netw Open. 2022;5(5):e2213643. doi:10.1001/jamanetworkopen.2022.13643.
- Park JS, Cho YJ, Yun J-Y, Lee HJ, Yu J, Yang H-J, Suh DI. Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series. Eur Respir J. 2022;60(5):2102467. Available from: https://erj.ersjournals.com/content/60/5/2102467 doi:10.1183/13993003.02467-2021.
- Baastrup Soendergaard M, Hansen S, Bjerrum A-S, von Bülow A, Haakansson KEJ, Hilberg O, Ingebrigtsen TS, Johnsen CR, Lock-Johansson S, Makowska Rasmussen L, et al. Psychiatric adverse effects of montelukast - a nationwide cohort study. J Allergy Clin Immunol Pract. 2023;S2213-2198(23):00294–00295.
- Probert-Lindström S, Berge J, Westrin Å, Öjehagen A, Pavulans KS. Long-term risk factors for suicide in suicide attempters examined at a medical emergency in patient unit: results from a 32-year follow-up study. BMJ Open. 2020;10(10):e038794. doi:10.1136/bmjopen-2020-038794.
- Beghi M, Butera E, Cerri CG, Cornaggia CM, Febbo F, Mollica A, Berardino G, Piscitelli D, Resta E, Logroscino G, et al. Suicidal behaviour in older age: a systematic review of risk factors associated to suicide attempts and completed suicides. Neurosci Biobehav Rev. 2021;127:193–211. doi:10.1016/j.neubiorev.2021.04.011.
- Hjorthøj CR, Madsen T, Agerbo E, Nordentoft M. Risk of suicide according to level of psychiatric treatment: a nationwide nested case–control study. Soc Psychiatry Psychiatr Epidemiol. 2014;49(9):1357–1365. doi:10.1007/s00127-014-0860-x.
- Goodwin RD. Asthma and suicide: current knowledge and future directions. Curr Psychiatry Rep. 2012;14(1):30–35. doi:10.1007/s11920-011-0243-x.
- Goodwin RD, Demmer RT, Galea S, Lemeshow AR, Ortega AN, Beautrais A. Asthma and suicide behaviors: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Psychiatr Res. 2012;46(8):1002–1007. doi:10.1016/j.jpsychires.2012.04.024.
- Zhang Y, Cheng J, Li Y, He R, Choudhry AA, Jiang J, Pan P, Su X, Hu C. Suicidality among patients with asthma: a systematic review and meta-analysis. J Affect Disord. 2019;256:594–603. doi:10.1016/j.jad.2019.06.031.
- Vargas PA, Robles E. Asthma and allergy as risk factors for suicidal behavior among young adults. J Am Coll Health. 2019;67(2):97–112. doi:10.1080/07448481.2018.1462822.
- Stewart C, Crawford PM, Simon GE. Changes in coding of suicide attempts or self-harm with transition from ICD-9 to ICD-10. Psychiatr Serv. 2017;68(3):215–215. doi:10.1176/appi.ps.201600450.